Jin Imai

Dr. Jin Imai

orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 December 2021 in JCI Insight
Verified
Journal Article
Open access
PDF file
JIJin Imai
Jin Imai
HIHitoshi Ichikawa
Hitoshi Ichikawa
SKSho Kitamoto
Sho Kitamoto
JGJonathan L. Golob
Jonathan L. Golob
MKMotoki Kaneko
Motoki Kaneko
NKNobuhiko Kamada
Nobuhiko Kamada
Oral conditions are relatively common in patients with inflammatory bowel disease (IBD). However, the contribution of oral maladies to gut inflammation remains unexplored. Here, we investigated the effect of periodontitis on disease phenotypes of patients with IBD. In all, 60 patients with IBD (42 with ulcerative colitis [UC] and 18 with Crohn’s disease [CD]) and 45 healthy controls (HCs) without IBD were recruited for this clinical investigation. The effects of incipient periodontitis on the oral and gut microbiome as well as IBD characteristics were examined. In addition, patients were prospectively monitored for up to 12 months after enrollment. We found that, in both patients with UC and those with CD, the gut microbiome was significantly more similar to the oral microbiome than in HCs, suggesting that ectopic gut colonization by oral bacteria is increased in patients with IBD. Incipient periodontitis did not further enhance gut colonization by oral bacteria. The presence of incipient periodontitis did not significantly affect the clinical outcomes of patients with UC and CD. However, the short CD activity index increased in patients with CD with incipient periodontitis but declined or was unchanged during the study period in patients without periodontitis. Thus, early periodontitis may associate with worse clinically symptoms in some patients with CD.

30 April 2020 in Intestinal Research
Verified
Journal Article
Open access
PDF file
JIJin Imai
Jin Imai
TYTakashi Yahata
Takashi Yahata
HIHitoshi Ichikawa
Hitoshi Ichikawa
AIAbd Aziz Ibrahim
Abd Aziz Ibrahim
MYMasaki Yazawa
Masaki Yazawa
KHKatsuto Hozumi
Katsuto Hozumi
Background/Aims: Intestinal fibrosis is a major complication of Crohn’s disease (CD). The profibrotic protein transforming growth factor-β (TGF-β) has been considered to be critical for the induction of the fibrotic program. TGF-β has the ability to induce not only the expression of extracellular matrix (ECM) including collagen, but also the production of plasminogen activator inhibitor-1 (PAI-1) that prevents enzymatic degradation of the ECM during the onset of fibrotic diseases. However, the significance of PAI-1 in the developing intestinal fibrosis has not been fully understood. In the present study, we examined the actual expression of PAI-1 in fibrotic legion of intestinal inflammation and its correlation with the abnormal ECM deposition.Methods: Chronic intestinal inflammation was induced in BALB/c mice using 8 repeated intrarectal injections of 2,4,6-trinitrobenzene sulfonic acid (TNBS). TM5275, a PAI-1 inhibitor, was orally administered as a carboxymethyl cellulose suspension each day for 2 weeks after the sixth TNBS injection.Results: Using a publicly available dataset (accession number, GSE75214) and TNBS-treated mice, we observed increases in PAI-1 transcripts at active fibrotic lesions in both patients with CD and mice with chronic intestinal inflammation. Oral administration of TM5275 immediately after the onset of intestinal fibrosis upregulated MMP-9 (matrix metalloproteinase 9) and decreased collagen accumulation, resulting in attenuation of the fibrogenesis in TNBS-treated mice.Conclusions: PAI-1-mediated fibrinolytic system facilitates collagen degradation suppression. Hence, PAI-1 inhibitor could be applied as an anti-fibrotic drug in CD treatment.

23 February 2023 in Frontiers in Microbiology
Verified
Journal Article
Open access
RTRika Tanaka
Rika Tanaka
JIJin Imai
Jin Imai
HTHitoshi Tsugawa
Hitoshi Tsugawa
KEKarl Bil Eap
Karl Bil Eap
MYMasaki Yazawa
Masaki Yazawa
KHKatsuto Hozumi
Katsuto Hozumi
Background and aim: Adherent-invasive E. coli (AIEC) has been identified as a pathobiont associated with Crohn’s disease (CD), that prefers to grow in inflammatory conditions. Although the colonization by AIEC is implicated in the progression of the disease and exacerbates inflammation in murine colitis models, the recognition and response of host immunity to AIEC remains elusive.Methods: Antibiotic treated female C57BL/6 mice were inoculated by commensal E. coli and LF82 AIEC strains. Luminal-IgA fractions were prepared from feces and their binding to AIEC and other strains was assessed to confirm specificity. IgA binding to isogenic mutant strains was performed to identify the functional molecules that are recognized by AIEC specific IgA. The effect of IgA on epithelial invasion of LF82 strain was confirmed using in vitro invasion assay and in vivo colonization of the colonic epithelium.Results: Persistent colonization by AIEC LF82 induced secretion of luminal IgA, while commensal E. coli strain did not. Induced anti-LF82 IgA showed specific binding to other AIEC strains but not to the commensal, non-AIEC E. coli strains. Induced IgA showed decreased binding to LF82 strains with mutated adhesin and outer membrane proteins which are involved in AIEC – epithelial cell interaction. Consistently, LF82-specific IgA limited the adhesion and invasion of LF82 in cultured epithelial cells, which seems to be required for the elimination in the colonic epithelium in mice.Conclusion: These results demonstrate that host immunity selectively recognizes pathobiont E. coli, such as AIEC, and develop specific IgA. The induced IgA specific to pathobiont E. coli, in turn, contributes to preventing the pathobionts from accessing the epithelium.

20 March 2016
Verified
Journal Article
Closed access
JIJin Imai
Jin Imai
HIHitoshi Ichikawa
Hitoshi Ichikawa
HMHajime Mizukami
Hajime Mizukami
TSTakayoshi Suzuki
Takayoshi Suzuki
NWNorihito Watanabe
Norihito Watanabe
TMTetsuya Mine
Tetsuya Mine

27 November 2022 in DEN Open
Verified
Journal Article
Open access
JIJin Imai
Jin Imai
THToru Hanamura
Toru Hanamura
AKAya Kawanishi
Aya Kawanishi
TUTakashi Ueda
Takashi Ueda
YMYusuke Mishima
Yusuke Mishima
YNYasuhiro Nishizaki
Yasuhiro Nishizaki
Breast cancer is one of the most common malignancies in women worldwide. Although most breast cancers are curable, in cases of metastasis, many are often found in the lungs, bones, liver, and central nervous system; however, metastasis to the gastrointestinal tract is rare. Invasive lobular carcinoma, which represents only 5%–10% of breast cancers, has a higher risk of metastasis to the gastrointestinal tract than invasive ductal carcinoma. Here, we report a rare case of gastrointestinal metastasis of invasive lobular carcinoma that spread extensively to the colonic mucosa. Given the improved survival rates of breast cancer patients with current treatments, many rarer metastatic diseases, including gastrointestinal metastases, are likely to be increased in the future.

20 December 2016
Verified
Journal Article
Closed access
HIHitoshi Ichikawa
Hitoshi Ichikawa
JIJin Imai
Jin Imai
HMHajime Mizukami
Hajime Mizukami
SUShuji Uda
Shuji Uda
SYSoichiro Yamamoto
Soichiro Yamamoto
HMHiroyasu Makuuchi
Hiroyasu Makuuchi